Quick Answer
Dyne Therapeutics, Inc. reported Net Income of -$446.21 million for fiscal year 2025.
Dyne Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$446.21M | -40.6% |
| 2024 | -$317.42M | -34.5% |
| 2023 | -$235.94M | -40.4% |
| 2022 | -$168.10M | -12.6% |
| 2021 | -$149.29M | -151.2% |
| 2020 | -$59.44M | -300.0% |
| 2019 | -$14.86M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$108.04M | -11.2% | +2.5% |
| June 30, 2025 | -$110.86M | -70.3% | +3.9% |
| March 31, 2025 | -$115.36M | -75.7% | -18.8% |
| September 30, 2024 | -$97.12M | -61.3% | -49.2% |
| June 30, 2024 | -$65.10M | -0.3% | +0.8% |
| March 31, 2024 | -$65.65M | -48.6% | -9.0% |
| September 30, 2023 | -$60.21M | -45.5% | +7.2% |
| June 30, 2023 | -$64.90M | -24.1% | -46.9% |
- Dyne Therapeutics, Inc. showed a decrease of -40.6% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Dyne Therapeutics, Inc.’s net income has declined by 2903.0% (from -$14.86 million to -$446.21 million).
- The most recent figure is from Dyne Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: